GO:0042770 signal transduction in response to DNA damage: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042770 (signal transduction in response to DNA damage) describes the intracellular signaling cascade triggered when a cell detects DNA damage, coordinating cell-cycle checkpoints, DNA repair, and cell-fate decisions.
• The ATM and ATR kinases are the master apical sensors/transducers of this response, with ATM responding primarily to double-strand breaks and ATR to single-stranded DNA and replication stress.
• Downstream phosphorylation of CHK1, CHK2, p53, and H2AX amplifies and executes the damage signal, controlling arrest, repair, senescence, or apoptosis.
• Defects in this signaling cascade cause cancer predisposition, neurodegeneration, immunodeficiency, and premature aging, and also determine tumor sensitivity to radiotherapy and DNA-damaging chemotherapy.
• Histone phosphorylation (notably H2AX) is a key chromatin-level amplification step that recruits repair and signaling factors to damage sites.
• CRISPR knockout, point-mutation, knock-in, and overexpression cell models, combined with CRISPR library screening and bioinformatics, are central tools for dissecting this pathway.
Description
The DNA damage response (DDR) is a highly coordinated network that protects genome integrity by detecting DNA lesions and converting that detection into intracellular signals that alter cell behavior. GO:0042770, signal transduction in response to DNA damage, captures the signaling arm of this network: the cascade of processes induced by the detection of DNA damage within a cell. This includes the activation of sensor and transducer kinases, the phosphorylation of downstream effectors, and the propagation of signals that control cell-cycle checkpoints, DNA repair, transcription, senescence, and apoptosis. Mechanistically, the response is initiated by sensor complexes that recognize distinct lesion types and recruit apical kinases, principally ATM and ATR, which phosphorylate hundreds of substrates to orchestrate the response. These phosphorylation events are not merely linear; they form branched, amplified, and feedback-regulated circuits that integrate damage type, cell-cycle phase, and cellular context. Histone modifications, especially phosphorylation of H2AX, provide chromatin-level amplification and docking platforms for repair and signaling factors. For researchers, GO:0042770 is a central node linking genome stability to human disease. Its dysfunction underlies cancer predisposition, neurodegeneration, immunodeficiency, and premature aging, while its status influences responses to radiotherapy and genotoxic chemotherapy. Understanding which genes and phosphorylation events drive the response, and how they can be experimentally manipulated, is therefore essential for both basic biology and therapeutic development.
signal transduction in response to DNA damage At A Glance
| GO ID | GO:0042770 |
|---|---|
| GO term | signal transduction in response to DNA damage |
| Ontology | biological_process |
| Synonym | DNA damage induced protein phosphorylation; DNA damage response, signal transduction; response to DNA damage stimulus by intracellular signaling cascade |
| Major function | Transduces detection of DNA lesions into intracellular signals controlling checkpoints, repair, and cell fate |
| Key apical kinases | ATM and ATR, with downstream CHK1 and CHK2 |
| Key effectors | p53, H2AX, and numerous phosphorylation substrates |
| Disease relevance | Cancer predisposition, neurodegeneration, immunodeficiency, premature aging, and radiotherapy response |
What Is GO:0042770?
GO:0042770 (signal transduction in response to DNA damage) is a biological process defined as a cascade of processes induced by the detection of DNA damage within a cell. In practical terms, it covers the intracellular signaling events that begin when sensor proteins recognize DNA lesions and culminate in the activation of effector pathways that determine cell fate and repair outcomes.
Why Is signal transduction in response to DNA damage Important in Cell Biology?
GO:0042770 is important because it converts the physical detection of DNA damage into biological decisions that determine whether a cell arrests, repairs, senesces, or dies. This signaling cascade is essential for tumor suppression and normal development, and its dysregulation is directly implicated in cancer, neurodegeneration, and aging-related disorders. Moreover, because radiotherapy and many chemotherapies act by inducing DNA damage, the status of this pathway strongly influences treatment sensitivity and resistance.
• Coordinates cell-cycle checkpoints that allow time for DNA repair before replication or mitosis.
• Determines cell fate decisions including survival, senescence, and apoptosis after damage.
• Protects against cancer by eliminating or arresting cells with oncogenic DNA lesions.
• Mediates sensitivity or resistance to radiotherapy and DNA-damaging chemotherapy.
• Is linked to neurodegeneration and premature aging when signaling is defective.
• Involves chromatin-level amplification via histone phosphorylation such as H2AX.
• Provides biomarkers and therapeutic targets, including ATM, ATR, CHK1, and CHK2.
• Is a model system for studying kinase signaling, feedback control, and systems-level network behavior.
What Happens During signal transduction in response to DNA damage?
Damage detection and sensor recruitment
In simple terms: First, specialized proteins spot the broken or damaged DNA and call in the signaling kinases.
The cascade begins when sensor complexes recognize distinct DNA lesions, such as double-strand breaks or single-stranded DNA, and recruit apical kinases to damage sites. This detection step is lesion-specific and provides the initial spatial and temporal cue for the entire response.
Activation of ATM and ATR kinases
In simple terms: The master kinases ATM and ATR get switched on and start tagging many proteins with phosphate groups.
ATM is primarily activated by double-strand breaks, whereas ATR responds to single-stranded DNA and replication stress. Once active, these kinases phosphorylate a large set of substrates, including CHK1, CHK2, p53, and H2AX, thereby amplifying and diversifying the damage signal.
Chromatin-level amplification via histone phosphorylation
In simple terms: Phosphorylation of histone H2AX creates landing pads on chromatin that recruit more signaling and repair factors.
Histone phosphorylation, especially H2AX, is a key chromatin modification that amplifies the damage signal and serves as a docking platform for repair and signaling proteins. This step links the initial kinase activation to broader chromatin remodeling and repair factor recruitment.
Checkpoint activation and cell-cycle arrest
In simple terms: The signal pauses the cell cycle so the cell has time to fix the damage.
Downstream kinases such as CHK1 and CHK2 phosphorylate cell-cycle regulators, leading to checkpoint activation and transient arrest in G1, S, or G2 phases. This arrest is a hallmark output of GO:0042770 and is essential for preventing replication or segregation of damaged DNA.
Effector decisions: repair, senescence, or apoptosis
In simple terms: Depending on the damage and context, the signal tells the cell to repair, stop dividing permanently, or self-destruct.
The signaling cascade converges on effectors such as p53 that integrate damage intensity and cellular context to promote DNA repair, senescence, or apoptosis. These fate decisions are central to tumor suppression and to the outcomes of genotoxic therapies.
Key Genes Involved in GO:0042770 signal transduction in response to DNA damage
The following genes and proteins are core components or well-characterized effectors of signal transduction in response to DNA damage (GO:0042770), based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATM | Apical kinase activated by double-strand breaks; phosphorylates CHK2, p53, H2AX | Central target for radiosensitization and cancer predisposition studies |
| ATR | Apical kinase responding to single-stranded DNA and replication stress | Key target in replication stress and chemotherapy combination studies |
| CHEK1 | Downstream kinase mediating checkpoint arrest and repair | Biomarker and target for ATR-CHK1 axis inhibition |
| CHEK2 | Downstream kinase activated by ATM; regulates p53 and cell cycle | Cancer predisposition gene and radiosensitivity modifier |
| TP53 | Effector transcription factor controlling arrest, senescence, and apoptosis | Most studied tumor suppressor in DDR signaling |
| H2AX | Histone variant phosphorylated at damage sites to amplify signaling | Classic marker of DNA damage and chromatin signaling |
| MDC1 | Mediator that binds H2AX and recruits ATM signaling complexes | Model for chromatin-based signal amplification |
| RAD50 | Component of the MRN sensor complex for double-strand breaks | Structural basis of damage sensing |
| MRE11 | Component of the MRN sensor complex with nuclease activity | Sensor complex assembly and end processing |
| NBN | Nibrin, component of MRN complex involved in damage sensing | Defects cause Nijmegen breakage syndrome |
| BRCA1 | Recruited to damage sites; influences repair pathway choice | Target for synthetic lethality and radiotherapy studies |
| BRCA2 | Homologous recombination factor recruited by DDR signaling | Cancer predisposition and PARP inhibitor response |
| CDKN1A | p21, effector of p53-mediated cell-cycle arrest | Readout of checkpoint activation |
| MDM2 | Negative regulator of p53 stability | Feedback control of the DDR effector arm |
| RPA1 | Single-stranded DNA binding protein that helps recruit ATR | Replication stress signaling model |
| TOPBP1 | Activator of ATR at damage sites | ATR activation mechanism studies |
| CLSPN | Claspin, adaptor for CHK1 activation | Checkpoint signaling dynamics |
| HUS1 | Component of the 9-1-1 clamp complex in ATR signaling | Rad9-Rad1-Hus1 checkpoint clamp studies |
How Is signal transduction in response to DNA damage Regulated?
The signaling cascade is tightly regulated by feedback loops and phosphatases that reset the pathway after damage is resolved. For example, MDM2 negatively regulates p53 stability, while multiple phosphatases counteract kinase activity to prevent chronic signaling. Chromatin modifications such as H2AX phosphorylation also provide spatial regulation by concentrating signaling at damage sites. In addition, pathway output is modulated by cell-cycle phase, damage type, and the availability of repair factors, making the response context-dependent.
signal transduction in response to DNA damage and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATM | Ataxia-telangiectasia; radiosensitivity; cancer predisposition | ATM knockout and point-mutation cell lines for radiosensitivity assays |
| CHEK2 | Cancer predisposition; impaired checkpoint signaling | CHEK2 knockout and kinase-dead knock-in models |
| TP53 | Li-Fraumeni syndrome; defective apoptosis and arrest | TP53 knockout and hotspot point-mutation models |
| BRCA1 | Hereditary breast and ovarian cancer; homologous recombination defect | BRCA1 knockout and knock-in models for PARP inhibitor studies |
| NBN | Nijmegen breakage syndrome; immunodeficiency | NBN knockout and patient-derived cell models |
Cancer predisposition and tumor suppression
Germline or somatic defects in DDR signaling genes such as ATM, CHEK2, BRCA1, and BRCA2 impair the ability to arrest or repair damaged cells, promoting genomic instability and cancer. The same defects can create therapeutic vulnerabilities, including sensitivity to DNA-damaging agents or PARP inhibitors.
Neurodegeneration and premature aging
Neurons are particularly vulnerable to DNA damage, and impaired DDR signaling is linked to neurodegeneration and premature aging phenotypes. Defective damage signaling can lead to accumulation of lesions and progressive loss of post-mitotic cells.
Radiotherapy and chemotherapy response
Because radiotherapy and many chemotherapies kill cells by inducing DNA damage, the status of GO:0042770 signaling strongly influences treatment sensitivity. Inhibitors of ATM, ATR, CHK1, and CHK2 are being explored to sensitize tumors to these modalities.
Immunodeficiency and developmental disorders
Inherited defects in damage sensing and signaling, such as those affecting the MRN complex, cause immunodeficiency and developmental abnormalities. These disorders highlight the non-cancer roles of the DDR in development and immune function.
From signal transduction in response to DNA damage-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a kinase required for damage-induced checkpoint arrest? | CRISPR knockout of ATM, ATR, CHEK1, or CHEK2 |
| Does a specific phosphorylation site control effector function? | Point-mutation knock-in of phospho-null or phospho-mimetic residues |
| How does a disease-associated variant affect signaling? | Knock-in of patient-derived mutations in ATM, CHEK2, or TP53 |
| Where and when does a protein localize after damage? | Endogenous tagged knock-in for imaging and proteomics |
| Does overexpression of a DDR gene alter sensitivity to DNA damage? | Doxycycline-inducible overexpression cell models |
| Which genes modulate the DDR in a genome-wide manner? | CRISPR library screening with DNA-damaging agents |
How to Study the signal transduction in response to DNA damage Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phospho-proteomics | Global phosphorylation changes after damage | Mapping kinase substrates and signaling dynamics |
| Immunofluorescence foci imaging | H2AX phosphorylation and repair factor recruitment | Visualizing damage signaling at chromatin |
| RNA sequencing | Transcriptional output of DDR effectors | p53 target gene and checkpoint profiling |
| CRISPR knockout screening | Gene requirements for survival after DNA damage | Discovering DDR modifiers and drug targets |
| Western blotting | Phosphorylation of ATM, CHK1, CHK2, p53 | Validating pathway activation |
| Comet assay | DNA breaks and repair kinetics | Linking signaling to repair outcomes |
| Cell-cycle analysis | Checkpoint arrest and progression | Functional readout of signaling |
| Kinase inhibitor profiling | Dependence on ATM, ATR, CHK1, CHK2 | Therapeutic target validation |
Phospho-proteomics and kinase substrate mapping
Mass spectrometry-based phospho-proteomics can identify substrates and dynamics of ATM, ATR, CHK1, and CHK2 after DNA damage, providing systems-level views of the signaling cascade. This approach is often combined with kinase inhibitors or genetic knockouts to assign phosphorylation events to specific kinases.
Imaging of damage foci and chromatin modifications
Fluorescence microscopy of H2AX phosphorylation, 53BP1, and other foci markers visualizes the spatial organization of the damage response and chromatin-level amplification. Live-cell imaging of tagged proteins can reveal recruitment kinetics and feedback dynamics.
Transcriptomics and checkpoint readouts
RNA sequencing after DNA damage can reveal transcriptional programs downstream of p53 and other effectors, including cell-cycle and apoptosis genes. These readouts complement protein-level assays to capture the full signaling output.
Functional genomics and CRISPR screening
CRISPR knockout and interference screens combined with DNA-damaging agents can identify genes that modify sensitivity or resistance, linking signaling components to therapeutic response. Such screens are powerful for discovering new DDR regulators and drug targets.
How CRISPR Can Be Used to Study GO:0042770 signal transduction in response to DNA damage
Knockout
CRISPR knockout of DDR signaling genes such as ATM, ATR, CHEK1, CHEK2, or TP53 allows researchers to test their requirement for damage-induced arrest, repair, and survival. Knockout cell models are widely used to assign signaling events to specific kinases and to study synthetic lethality with DNA-damaging agents.
Point Mutation
Point-mutation knock-in of phospho-null, phospho-mimetic, or disease-associated residues enables precise dissection of phosphorylation-dependent signaling and variant pathogenicity. Such models are particularly valuable for separating kinase scaffolding functions from catalytic activity.
Knock-in
Knock-in of endogenous tags or reporter cassettes allows visualization and proteomic analysis of DDR proteins at their native loci, preserving physiological regulation. This approach supports imaging of recruitment kinetics and interaction mapping at damage sites.
Overexpression
Inducible overexpression of DDR genes can test whether increased signaling is sufficient to trigger checkpoint arrest, senescence, or apoptosis, and can model tumors with pathway amplification. Overexpression models are also useful for testing dominant-negative or constitutively active variants.
How EDITGENE Supports signal transduction in response to DNA damage Research
Researchers studying signal transduction in response to DNA damage-related genes often need to determine whether a candidate gene is causally involved in damage sensing, checkpoint control, or cell-fate decisions. Rigorous causal testing requires well-controlled genetic models that isolate the gene of interest and its specific domains or phosphorylation sites.
Contact EDITGENE today to design your custom CRISPR model for signal transduction in response to DNA damage research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| WNT1 Knockout HEK293 Cell Line | EDJ-KQ118 | Human | 7471 | Details Get a Quote |
| MAP3K7 Knockout HEK293 Cell Line | EDJ-KQ142 | Human | 6885 | Details Get a Quote |
| CASP9 Knockout HEK293 Cell Line | EDJ-KQ183 | Human | 842 | Details Get a Quote |
| ATM Knockout HEK293T Cell Line | EDJ-KQ211 | Human | 472 | Details Get a Quote |
| MAPK3 Knockout HEK293 Cell Line | EDJ-KQ391 | Human | 5595 | Details Get a Quote |
| GADD45A Knockout HEK293 Cell Line | EDJ-KQ563 | Human | 1647 | Details Get a Quote |
| MAPK14 Knockout HEK293 Cell Line | EDJ-KQ700 | Human | 1432 | Details Get a Quote |
| MAP2K6 Knockout HEK293 Cell Line | EDJ-KQ1353 | Human | 5608 | Details Get a Quote |
| MAPK12 Knockout HEK293 Cell Line | EDJ-KQ1354 | Human | 6300 | Details Get a Quote |
| BID Knockout HEK293 Cell Line | EDJ-KQ1746 | Human | 637 | Details Get a Quote |
| CRY1 Knockout HEK293 Cell Line | EDJ-KQ3045 | Human | 1407 | Details Get a Quote |
| CHEK2 Knockout HEK293 Cell Line | EDJ-KQ7330 | Human | 11200 | Details Get a Quote |
| FBXO31 Knockout HEK293 Cell Line | EDJ-KQ7448 | Human | 79791 | Details Get a Quote |
| CEP63 Knockout HEK293 Cell Line | EDJ-KQ9512 | Human | 80254 | Details Get a Quote |
| ABL1 Knockout HEK293 Cell Line | EDJ-KQ17798 | Human | 25 | Details Get a Quote |
Displaying Records 1 To 15 Of 67 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About signal transduction in response to DNA damage
What is GO:0042770 signal transduction in response to DNA damage?
GO:0042770 is a biological process describing the cascade of intracellular signaling events induced when a cell detects DNA damage, coordinating checkpoints, repair, and cell fate.
What genes are involved in signal transduction in response to DNA damage?
Core genes include ATM, ATR, CHEK1, CHEK2, TP53, H2AX, MDC1, and MRN complex components such as MRE11, RAD50, and NBN.
How does ATM differ from ATR in the DNA damage response?
ATM is primarily activated by double-strand breaks, while ATR responds mainly to single-stranded DNA and replication stress.
Why is H2AX phosphorylation important in DNA damage signaling?
Phosphorylated H2AX amplifies the damage signal and recruits repair and signaling factors to chromatin around damage sites.
What diseases are linked to defects in DNA damage signaling?
Defects are linked to cancer predisposition, neurodegeneration, immunodeficiency, and premature aging, and they influence radiotherapy response.
How is signal transduction in response to DNA damage studied experimentally?
Common methods include phospho-proteomics, foci imaging, RNA sequencing, CRISPR knockout screens, and kinase inhibitor profiling.
Can CRISPR knockout be used to study DNA damage signaling genes?
Yes, CRISPR knockout of genes such as ATM, ATR, CHEK1, CHEK2, and TP53 is widely used to test their roles in checkpoint control and survival.
What is the role of p53 in the DNA damage response?
p53 is a key effector that integrates damage signals to trigger cell-cycle arrest, senescence, or apoptosis.
Why is the DNA damage response important for cancer therapy?
Many therapies act by inducing DNA damage, so the status of this signaling pathway determines sensitivity or resistance to treatment.
What experimental models are used to study DNA damage signaling?
Models include CRISPR knockout, point-mutation knock-in, tagged knock-in, overexpression cell lines, and CRISPR library screens.
Conclusion
GO:0042770 (signal transduction in response to DNA damage) is a central biological process that converts DNA lesion detection into coordinated cellular decisions, including checkpoint arrest, repair, senescence, and apoptosis. Its core kinases ATM and ATR, downstream effectors such as CHK1, CHK2, and p53, and chromatin modifications like H2AX phosphorylation form an integrated network with broad relevance to cancer, neurodegeneration, and aging. Because this pathway determines responses to radiotherapy and genotoxic chemotherapy, it is a major focus for therapeutic targeting and biomarker development. CRISPR-based knockout, point-mutation, knock-in, overexpression, and library screening approaches provide powerful tools to dissect its mechanisms and translate findings into clinical insights.
References
- 1. Jackson SP et al.. 2009. The DNA-damage response in human biology and disease.. Nature 461(7267):1071-8 PMID: 19847258
- 2. Ciccia A et al.. 2010. The DNA damage response: making it safe to play with knives.. Mol Cell 40(2):179-204 PMID: 20965415
- 3. Huang RX et al.. 2020. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer.. Signal Transduct Target Ther 5(1):60 PMID: 32355263
- 4. Maréchal A et al.. 2013. DNA damage sensing by the ATM and ATR kinases.. Cold Spring Harb Perspect Biol 5(9) PMID: 24003211
- 5. Sancar A et al.. 2004. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints.. Annu Rev Biochem 73:39-85 PMID: 15189136
- 6. Borgmann K et al.. 2016. DNA Repair.. Recent Results Cancer Res 198:1-24 PMID: 27318679
- 7. Giglia-Mari G et al.. 2011. DNA damage response.. Cold Spring Harb Perspect Biol 3(1):a000745 PMID: 20980439
- 8. Gong P et al.. 2025. Histone Phosphorylation in DNA Damage Response.. Int J Mol Sci 26(6) PMID: 40141048
